However, since fenofibrate treatment reduced islet size and decreased insulin-secreting β-cell areas in HFD mice to levels similar to those in LFD mice, normalization of β-cell mass by fenofibrate is likely to lower circulating insulin levels and suppress insulin resistance during obesity in OVX mice. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.